---
content_type: page
description: This section provides details on the required text for the course and
  the schedule of assigned readings by session and topic.
learning_resource_types:
- Readings
ocw_type: CourseSection
title: Readings
uid: c34bfc6f-94a3-b414-e525-9756e0fb812a
---

\*\*\* These articles are required reading, and are of particular importance and interest. Graduate students are responsible for **all** articles.

Required Text
-------------

Cooper, Jack R., Floyd E. Bloom, and Robert H. Roth. _The Biochemical Basis of Neuropharmacology_. 8th ed. Oxford, UK: Oxford University Press, 2002. ISBN: 9780195140088.

{{< tableopen >}}
{{< theadopen >}}
{{< tropen >}}
{{< thopen >}}
SES #
{{< thclose >}}
{{< thopen >}}
TOPICS
{{< thclose >}}
{{< thopen >}}
READINGS
{{< thclose >}}

{{< trclose >}}

{{< theadclose >}}
{{< tropen >}}
{{< tdopen >}}
1
{{< tdclose >}}
{{< tdopen >}}
Neurotransmitters, receptors, and actions
{{< tdclose >}}
{{< tdopen >}}


Cooper, Bloom, and Roth. "Introduction." Chapter 1, pp. 1-6.

———. "Cellular Foundations of Neuropharmacology." Chapter 2, pp. 7-37.

———. "Molecular Foundations of Neuropharmacology." Chapter 3, pp. 39-64.

\*\*\* Funk, C. D. "Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology." _Science_ 294 (2001): 1871-1875.

\*\*\* Corbin J. D., S. H. Francis, and D. J. Webb. "Phosphodiesterase Type 5 as a Pharmacologic Target in Erectile Dysfunction." _Urology_ 60, 2, Suppl. 2 (2002): 4-11.

Moncada, S., and A. Higgs. "The L-Arginine-Nitric Oxide Pathway." _N Engl J Med_ 329, no. 27 (1993): 2002-2012.

Snyder, S. H., and G. W. Pasternak. "Historical Review: Opioid Receptors." _Trends Pharmacol Sci_ 24, no. 4 (April 2003): 198-205.


{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
2
{{< tdclose >}}
{{< tdopen >}}
Membranes and the blood brain barrier
{{< tdclose >}}
{{< tdopen >}}


\*\*\* Laterra, J., R. Keep, L. A. Betz, and G. W. Goldstein. "Blood-Brain Barrier." In _Basic Neurochemistry: Molecular, Cellular, and Medical Aspects_. Edited by George J. Siegel, Bernard W. Agranoff, R. Wayne Albers, Stephen K. Fisher, and Michael D. Uhler. Baltimore, MD: Lippincott Williams & Wilkins, c1999. ISBN: 9780397518203.

\*\*\* Pardridge, W. M. "Regulation of Amino Acid Availability to the Brain." In _Nutrition and the Brain_. Vol. 1. Edited by R. J. Wurtman and J. J. Wurtman. New York, NY: Raven Press, 1977, pp. 142-175. ISBN: 9780890040454.

\*\*\* Wurtman, R. J., et al. "Synaptic Proteins and Phospholipids are Increased in Gerbil Brain by Administering Uridine Plus DHA Orally." _Brain Research_ 1088 (2006): 83-92.

Kang, J. X., et al. "_Fat-1_ Mice Convert _n_\-6 to _n_\-3 Fatty Acids." _Nature_ 427 (2004): 504.

Pooler, A., et al. "Uridine Enhances Neurite Outgrowth in NGF-Differentiated PC-12 Cells." _Neuroscience_ 134 (2005): 207-214.


{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
3
{{< tdclose >}}
{{< tdopen >}}
Acetylcholine: biochemistry
{{< tdclose >}}
{{< tdopen >}}


Cooper, Bloom, and Roth. "Acetylcholine." Chapter 7, pp. 151-179.

\*\*\* Ulus, I. H., R. J. Wurtman, C. Mauron, and J. K. Blusztajn. "Choline Increases Acetylcholine Release and Protects Against the Stimulation-Induced Decrease in Phosphatide Levels within Membranes of Rat Corpus Striatum." _Brain Research_ 484 (1989): 217-227.

Wurtman, Cansev, and Ulus. "Choline and Its Products, Acetylcholine, and Phosphatidylcholine." _Handbook of Neurochemistry,_ 2007, pp. 3-38.


{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
4
{{< tdclose >}}
{{< tdopen >}}
Acetylcholine: Alzheimer's disease
{{< tdclose >}}
{{< tdopen >}}


Cooper, Bloom, and Roth. "Treating Neurological and Psychiatric Diseases." Chapter 13, pp. 373-400.

\*\*\* Selkoe, D. J. "Alzheimer's Disease is a Synaptic Failure." _Science_ 298 (2002): 789-791.

Nitsch R. M., J. K. Blusztajn, A. G. Pittas, B. E. Slack, J. H. Growdon, and R. J. Wurtman. "Evidence for a Membrane Defect in Alzheimer Disease." _Brain Proc Natl Acad Sci USA_ 89 (1992): 1671-1675.

Tuszynski, M. H., L. Thal, M. Pay, D. P. Salmon, U HS, R. Bakay, P. Patel, A. Blesch, H. L. Vahlsing, Ho G, G. Tong, S. G. Potkin, J. Fallon, L. Hansen, E. J. Mufson, J. H. Kordower, C. Gall, and J. Conner. "A Phase 1 Clinical Trial of Nerve Growth Factor Gene Therapy for Alzheimer Disease." _Nat Med_ 11, no. 5 (May 2005): 551-555.


{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
5
{{< tdclose >}}
{{< tdopen >}}
Dopamine: biochemistry and Parkinson's disease
{{< tdclose >}}
{{< tdopen >}}


Cooper, Bloom, and Roth. "Dopamine." Chapter 9, pp. 225-270.

———. "Treating Neurological and Psychiatric Diseases." Chapter 13, pp. 373-400.

\*\*\* Hokfelt, T., J. F. Rehfeld, L. Skirboll, B. Ivemark, M. Goldstein, and K. Markey. "Evidence for Coexistence of Dopamine and CCK in Meso-Limbic Neurones." _Nature_ 285 (1980): 476-477.

\*\*\* Burns, R. S., P. A. LeWitt, M. H. Ebert, H. Pakkenberg, and I. J. Kopin. "The Clinical Syndrome of Striatal Dopamine Deficiency." _N Engl J Med_ 312, no. 22 (1985): 1418-1421.

\*\*\* Acworth, I. N., M. J. During, and R. J. Wurtman. "Tyrosine: Effects on Catecholamine Release." _Brain Res Bull_ 21, no. 3 (1988): 473-477.

Bezard, E., S. Ferry, U. Mach, H. Stark, L. Leriche, T. Boraud, C. Gross, and P. Sokoloff. "Attenuation of Levodopa-Induced Dyskinesia by Normalizing Dopamine D(3) Receptor Function." _Nat Med_ 9, no. 6 (2003): 762-767.

Knecht, S., C. Breitenstein, S. Bushuven, S. Wailke, S. Kamping, A. Floel, P. Zwitserlood, and E. B. Ringelstein. "Levodopa: Faster and Better Word Learning in Normal Humans." _Ann Neurol_ 56, no. 1 (July 2004): 20-26.

Cansev, M., and R. J. Wurtman. "Aromatic Amino Acids." In _Handbook of Neurochemistry and Molecular Neurobiology_. Vol. 6, chapter 3, 2006, pp. 60-97.


{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
6
{{< tdclose >}}
{{< tdopen >}}
Norepinephrine and epinephrine
{{< tdclose >}}
{{< tdopen >}}


Cooper, Bloom, and Roth. "Norepinephrine and Epinephrine." Chapter 8, pp. 181-223.

———. "Treating Neurological and Psychiatric Diseases." Chapter 13, pp. 373-400.

\*\*\* Wurtman, R. J., and J. Axelrod. "Control of Enzymatic Synthesis of Adrenaline in the Adrenal Medulla by Adrenal Cortical Steroids." _J Biol Chem_ 241, no. 10 (1966): 2301-2305.

\*\*\* Berridge, C. W., and B. D. Waterhouse. "The Locus Coeruleus-Noradrenergic System: Modulation of Behavioral State and State-Dependent Cognitive Processes." _Brain Res Rev_ 42 (2003): 33-84.

Insel, P. A. "Adrenergic Receptors-Evolving Concepts and Clinical Implications." _N Engl J Med_ 334, no. 9 (1996): 580-585.

Melamed, E., F. Hefti, and R. J. Wurtman. "Tyrosine Administration Increases Striatal Dopamine Release in Rats with Partial Nigrostriatal Lesions." _PNAS_ 77, no. 7 (1980): 4305-4309.

Conlay, L. A., T. J. Maher, and R. J. Wurtman. "Tyrosine Increases Blood Pressure in Hypotensive Rats." _Science_ 212, no. 4494 (1981): 559-560.


{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
7
{{< tdclose >}}
{{< tdopen >}}
Serotonin: biochemistry
{{< tdclose >}}
{{< tdopen >}}


Cooper, Bloom, and Roth. "Serotonin, Histamine, and Adenosine." Chapter 10, pp. 271-304.

———. "Treating Neurological and Psychiatric Diseases." Chapter 13, pp. 373-400.

\*\*\* Fernstrom, J. D., and R. J. Wurtman. "Brain Serotonin Content: Physiological Dependence on Plasma Tryptophan Levels." _Science_ 173 (1971): 149-152.

\*\*\* ———. "Brain Serotonin Content: Physiological Regulation by Plasma Neutral Amino Acids." _Science_ 178 (1972): 414-416.

\*\*\* Wurtman, R. J., and J. J. Wurtman. "Carbohydrates and Depression." _Scientific American_ 1 (1989): 68-75.

\*\*\* Schaechter, J. D., and R. J. Wurtman. "Tryptophan Availability Modulates Serotonin Release from Rat Hypothalamic Slices." _J Neurochem_ 53, no. 6 (1989): 1925-1933.

\*\*\* Wurtman, R. J., J. J. Wurtman, M. M. Regan, J. M. McDermott, R. H. Tsay, and J. J. Breu. "Effects of Normal Meals Rich in Carbohydrates or Proteins on Plasma Tryptophan and Tyrosine Ratios." _Am J Clin Nutr_ 77, no. 1 (January 2003): 128-132.

Fernstrom, J. D., and R. J. Wurtman. "Brain Serotonin Content: Increase Following Ingestion of Carbohydrate Diet." _Science_ 174 (1971): 1023-1025.


{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
8
{{< tdclose >}}
{{< tdopen >}}
Serotonin: behavior, and obesity
{{< tdclose >}}
{{< tdopen >}}


\*\*\* Nishizawa, S., C. Benkelfat, S. N. Young, M. Leyton, S. Mzengeza, C. de Montigny, P. Blier, and M. Diksic. "Differences between Males and Females in Rates of Serotonin Synthesis in Human Brain." _Proc Natl Acad Sci USA_ 94 (1997): 5308-5313.

\*\*\* Austin, M. C., R. E. Whitehead, C. L. Edgar, J. E. Januaryosky, and D. A. Lewis. "Localized Decrease in Serotonin Transporter-Immunoreactive Axons in the Prefrontal Cortex of Depressed Subjects Committing Suicide." _Neuroscience_ 114, no. 3 (2002): 807-815.

\*\*\* Caspi, A., K. Sugden, T. E. Moffitt, A. Taylor, I. W. Craig, H. Harrington, J. McClay, J. Mill, J. Martin, A. Braithwaite, and R. Poulton. "Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT Gene." _Science_ 301, no. 5631 (2003): 386-389.

\*\*\* Fava, M., and K. S. Kendler. "Major Depressive Disorder." _Neuron_ 28, no. 2: 335-341.

Zhang, X., R. R. Gainetdinov, J. M. Beaulieu, T. D. Sotnikova, L. H. Burch, R. B. Williams, D. A. Schwartz, K. R. Krishnan, and M. G. Caron. "Loss-of-Function Mutation in Tryptophan Hydroxylase-2 Identified in Unipolar Major Depression." _Neuron_ 45, no. 1 (January 6, 2005): 11-16.

"Zelnorm gets US FDA OK for Chronic Constipation." _SCRIP_ (August 27, 2004).

"The Link Between Ecstasy, Depression and Genetics." _The Economist_ (March 21, 2005).

Wurtman, J. J., and R. J. Wurtman. "_D_\-Fenfluramine Selectively Decreases Carbohydrate But Not Protein Intake in Obese Subjects." _Intl J Obesity_ 8, no. 1 (1984): 79-84.

Meltzer, H. "Illuminating the Molecular Basis for Some Antipsychotic Drug-Induced Metabolic Burden." _PNAS_ 104 (2007): 3019-3020.


{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
9
{{< tdclose >}}
{{< tdopen >}}
Review
{{< tdclose >}}
{{< tdopen >}}
 
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
10
{{< tdclose >}}
{{< tdopen >}}
Hour examination - midterm
{{< tdclose >}}
{{< tdopen >}}
 
{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
11
{{< tdclose >}}
{{< tdopen >}}
Melatonin
{{< tdclose >}}
{{< tdopen >}}


\*\*\* Wurtman, R. J. "Melatonin." _Encyclopedia of Dietary Supplements,_ 2005, pp. 457-466.

Wurtman, R. J., J. Axelrod, and Chu E. W. "Melatonin, A Pineal Substance: Effect on the Rat Ovary." _Science_ 141 (1963): 277-278.

Lynch, H. J., R. J. Wurtman, M. A. Moskowitz, M. C. Archer, and M. H. Ho. "Daily Rhythm in the Human Urinary Melatonin." _Science_ 187 (1975): 169-171.

Zhdanova, I. V., R. J. Wurtman, M. M. Regan, J. A. Taylor, J. P. Shi, and O. U. Leclair. "Melatonin Treatment for Age-Related Insomnia." _J Clin Endocrin Metab_ 86, no. 10 (2001): 4727-4730.

Gerdin, M. J., M. I. Masana, M. A. Rivera-Bermudez, R. L. Hudson, D. J. Earnest, M. U. Gillette, and M. L. Dubocovich. "Melatonin Desensitizes Endogenous MT2 Melatonin Receptors in the Rat Suprachiasmatic Nucleus: Relevance for Defining the Periods of Sensitivity of the Mammalian Circadian Clock to Melatonin." _FASEB J_ 18, no. 14 (November 2004): 1646-1656.

Wurtman, R. J. "Ramelteon: A Novel Treatment for the Treatment of Insomnia." _Expert RSV Neurother_ 6 (2006): 957-964.


{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
12-13
{{< tdclose >}}
{{< tdopen >}}
Glutamate: biochemistry, learning and toxicity
{{< tdclose >}}
{{< tdopen >}}


Cooper, Bloom, and Roth. "Molecular Foundations of Neuropharmacology." Chapter 3, pp. 59-64.

———. "Modulation of Synaptic Transmission." Chapter 5, pp. 85-104.

———. "Amino Acid Transmitters." Chapter 6, pp. 132-150.

———. "Cellular Mechanisms in Learning and Memory." Chapter 12, pp. 357-372.

\*\*\* Mothet, J. P., A. T. Parent, H. Wolosker, R. O. Brady Jr., D. J. Linden, C. D. Ferris, M. A. Rogawski, and S. H. Snyder. "D-Serine is an Endogenous Ligand for the Glycine Site of the N-Methyl-D-Aspartate Receptor." _Proc Natl Acad Science USA_ 97, no. 9 (2000): 4926-4931.

\*\*\* Malenka, R. C., and M. F. Bear. "LTP and LTD: An Embarrassment of Riches." _Neuron_ 44, no. 1 (September 30, 2004): 5-21.

\*\*\* Südhof, T. C. "The Synaptic Vesicle Cycle Revisited." _Neuron_ 28, no. 2 (2000): 317-320.

Krystal, J. H., et al. "NMDA Agonists and Antagonists as Probes of Glutamatergic Dysfunction and Pharmacotherapies in Neuropsychiatric Disorders." _Harvard Rev Psychiatry_ 7 (1999): 125-143.

Fon, E. A., and R. H. Edwards. "Molecular Mechanisms of Neurotransmitter Release." _Muscle Nerve_ 24, no. 5 (2001): 581-601.


{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
14
{{< tdclose >}}
{{< tdopen >}}
GABA: anxiety, seizures
{{< tdclose >}}
{{< tdopen >}}


Cooper, Bloom, and Roth. "Amino Acid Transmitters." Chapter 6, pp. 105-132.

\*\*\* Gale, K., and M. J. Iadarola. "Seizure Protection and Increased Nerve-Terminal GABA: Delayed Effects of GABA Transmission Inhibition." _Science_ 208 (1980): 288-291.

Wang, L., T. J. Maher, and R. J. Wurtman. "Oral L-Glutamine Increases GABA Levels in Striatal Tissue and Extracellular Fluid." _FASB J_ 21 (2007): 1227-1232.

Nie, Z., P. Schweitzer, A. J. Roberts, S. G. Madamba, S. D. Moore, and G. R. Siggins. "Ethanol Augments GABAergic Transmission in the Central Amygdala via CRF1 Receptors." _Science_ 303, no. 5663 (March 5, 2004): 1512-1514.


{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
15
{{< tdclose >}}
{{< tdopen >}}
Glycine and histamine
{{< tdclose >}}
{{< tdopen >}}


Cooper, Bloom, and Roth. "Serotonin, Histamine, and Adenosine." Chapter 10, pp. 304-320.

\*\*\* Betz, H., and C. M. Becker. "The Mammalian Glycine Receptor: Biology and Structure of a Neuronal Chloride Channel Protein." _Neurochem Int_ 13, no. 2 (1988): 137-146.

\*\*\* Anagnostaras, S. G., M. G. Craske, and M. S. Fanselow. "Anxiety: At the Intersection of Genes and Experience." _Nature Neurosci_ 2, no. 9 (1999): 780-782.

\*\*\* Shankley, N. P., G. F. Watt, and J. W. Black. "Definition and Localization of Histamine H2 Receptors." _Euro J Clin Investig_ 25, no. 1 (1995): 12-18.

Rogawski, M. A. "Progesterone, Neurosteroids, and the Hormonal Basis of Catamenial Epilepsy." _Ann Neurol_ 53, no. 3 (2003): 288-290.

Simons, F. E. R., and K. J. Simons. "The Pharmacology and Use of H1-Receptor-Antagonist Drugs." _New England J Med_ 330, no. 23 (1994): 1663-1670.

Masaki, T., S. Chiba, G. Yoshimichi, T. Yasuda, H. Noguchi, T. Kakuma, T. Sakata, and H. Yoshimatsu. "Neuronal Histamine Regulates Food Intake, Adiposity, and Uncoupling Protein Expression in Agouti Yellow (A(y)/a) Obese Mice." _Endocrinology_ 144, no. 6 (2003): 2741-2748.


{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
16
{{< tdclose >}}
{{< tdopen >}}
Cannabinoids and adenosine
{{< tdclose >}}
{{< tdopen >}}


Cooper, Bloom, and Roth. "Serotonin, Histamine, and Adenosine." Chapter 10, pp. 317-320.

\*\*\* Fredholm, B. B. "Adenosine Receptors in the Central Nervous System." _NIPS_ 10 (1995): 122-128.

\*\*\* Goutopoulos, A., and A. Makriyannis. "From Cannabis to Cannabinergics: New Therapeutic Opportunities." _Pharmacol Ther_ 95, no. 2 (2002): 103-117.

\*\*\* Wilson, R. I., and R. A. Nicoll. "Endocannabinoid Signaling in the Brain." _Science_ 296, no. 5568 (2002): 678-682.

Conlay, L. A., J. A. Conant, F. deBros, and R. J. Wurtman. "Caffeine Alters Plasma Adenosine Levels." _Nature_ 389 (1997): 136.


{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
17
{{< tdclose >}}
{{< tdopen >}}
Brain peptides
{{< tdclose >}}
{{< tdopen >}}


Cooper, Bloom, and Roth. "Neuroactive Peptides." Chapter 11, pp. 321-356.

\*\*\* Nichols, M. L., et al. "Transmission of Chronic Nociception by Spinal Neurons Expressing the Substance P Receptor." _Science_ 268 (1999): 1558-1561.

\*\*\* Selmer, I-S., M. Schindler, J. P. Allen, P. P. A. Humphrey, and P.C. Emson. "Advances in Understanding Neuronal Somatostatin Receptors." _Regulatory Peptides_ 90 (2000): 1-18.

\*\*\* Degen, L., D. Matzinger, J. Drewe, and C. Beglinger. "The Effect of Cholecystokinin in Controlling Appetite and Food Intake in Humans." _Peptides_ 22, no. 8 (2001): 1265-1269.

Schwartz, M. W., S. C. Woods, D. Porte Jr., R. J. Seeley, and D. G. Baskin. "Central Nervous System Control of Food Intake." _Nature_ 404 (2000): 661-671.

Wurtman, R. J. "Narcolepsy and the Hypocretins." _Metabolism_ 55 (2006): 536-539.


{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
18
{{< tdclose >}}
{{< tdopen >}}
Drug development and review
{{< tdclose >}}
{{< tdopen >}}


Cooper, Bloom, and Roth. "Treating Neurological and Psychiatric Diseases." Chapter 13, pp. 373-400.

\*\*\* Wurtman, R. J., and R. L. Bettiker. "The Slowing of Treatment Discovery, 1965-1995." _Nat Med_ 1, no. 11 (1995): 1122-1125.

\*\*\* Wurtman, R. J. "What Went Right: Why is HIV a Treatable Infection?" _Nat Med_ 3, no. 7 (1997): 714-717.


{{< tdclose >}}

{{< trclose >}}
{{< tropen >}}
{{< tdopen >}}
19
{{< tdclose >}}
{{< tdopen >}}
Hour examination - final
{{< tdclose >}}
{{< tdopen >}}
 
{{< tdclose >}}

{{< trclose >}}

{{< tableclose >}}